Literature DB >> 8458907

Analysis of polyols in uremic serum by liquid chromatography combined with atmospheric pressure chemical ionization mass spectrometry.

T Niwa1, K Tohyama, Y Kato.   

Abstract

Liquid chromatography with atmospheric pressure chemical ionization mass spectrometry in the negative-ion mode was used to analyse polyols in uremic serum obtained from haemodialysis patients. With post-column addition of 1% chloroform-methanol as an ionization accelerating solvent, the chloride addition ions, [M+Cl]-, were detected as base peaks, and the molecular masses of the polyols were easily determined by comparing [M+Cl]- and [M - H]- ions. Concentrations of erythritol, myoinositol, mannitol and sorbitol were markedly increased, and that of 1,5-anhydroglucitol was markedly decreased in the uremic serum compared with normal serum. After haemodialysis, the serum concentration of these polyols decreased significantly. This method was found to be useful in analysing the profile of polyols.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8458907     DOI: 10.1016/0378-4347(93)80191-6

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Erythritol is a pentose-phosphate pathway metabolite and associated with adiposity gain in young adults.

Authors:  Katie C Hootman; Jean-Pierre Trezzi; Lisa Kraemer; Lindsay S Burwell; Xiangyi Dong; Kristin A Guertin; Christian Jaeger; Patrick J Stover; Karsten Hiller; Patricia A Cassano
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-08       Impact factor: 11.205

2.  A novel NAD-dependent dehydrogenase, highly specific for 1,5-anhydro-D-glucitol, from Trichoderma longibrachiatum strain 11-3.

Authors:  Nobuyuki Yoshida; Etsuko Uchida; Tohoru Katsuragi; Yoshiki Tani
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

3.  Ranirestat for the management of diabetic sensorimotor polyneuropathy.

Authors:  Vera Bril; Toshiyuki Hirose; Sasagu Tomioka; Robert Buchanan
Journal:  Diabetes Care       Date:  2009-04-14       Impact factor: 19.112

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.